• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Yamo Reports Positive Phase 2 Results For Autism Treatment L1-79

    30 Jul 2024 //

    GLOBENEWSWIRE

    Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79

    20 Nov 2023 //

    GLOBENEWSWIRE

    Yamo Pharma doses first subject in Phase II autism spectrum disorder trial

    28 Jan 2022 //

    CLINICALTRIALSARENA

    Yamo Pharma Begins Enrollment in Phase 2 Study of L1-79 in ASD

    27 Jan 2022 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.